A review of smoking cessation interventions.
作者信息
Maseeh Ashish, Kwatra Gagandeep
机构信息
Department of Pharmacology, Christian Medical College & Hospital, Ludhiana, India.
出版信息
MedGenMed. 2005 Jun 7;7(2):24.
Abstract
摘要
相似文献
1
A review of smoking cessation interventions.戒烟干预措施综述
MedGenMed. 2005 Jun 7;7(2):24.
2
Smoking Coca Paste and crack-tobacco must be treated as double addiction.吸食古柯糊和快克可卡因必须被视为双重成瘾。
Subst Abus. 2009 Jan-Mar;30(1):81. doi: 10.1080/08897070802606519.
3
Treatment of nicotine addiction: present therapeutic options and pipeline developments.尼古丁成瘾的治疗：现有治疗选择和研发管线进展。
Trends Pharmacol Sci. 2011 May;32(5):281-9. doi: 10.1016/j.tips.2010.12.008. Epub 2011 Jan 20.
4
[Nicotine, a killing faker].
Rev Mal Respir. 2012 Apr;29(4):445-7. doi: 10.1016/j.rmr.2012.02.006. Epub 2012 Mar 23.
5
Sex differences in long-term smoking cessation rates due to nicotine patch.尼古丁贴片导致的长期戒烟率的性别差异。
Nicotine Tob Res. 2008 Jul;10(7):1245-50. doi: 10.1080/14622200802097506.
6
Update in New Jersey tobacco-dependence treatment.新泽西州烟草依赖治疗的最新情况。
N J Med. 2002 Nov;99(11):21-6.
7
When California smokers use nicotine replacement therapy, most are trying to quit smoking.当加利福尼亚州的吸烟者使用尼古丁替代疗法时，大多数人是在试图戒烟。
Tob Control. 2005 Oct;14(5):359-60. doi: 10.1136/tc.2005.012989.
8
Over-the-counter nicotine replacement therapy: can its impact on smoking cessation be enhanced?非处方尼古丁替代疗法：其对戒烟的影响能否得到增强？
Psychol Addict Behav. 2008 Dec;22(4):472-85. doi: 10.1037/0893-164X.22.4.472.
9
A quantitative estimate of the clinical significance of treating tobacco dependence.对治疗烟草依赖临床意义的定量评估。
Am J Prev Med. 2010 Sep;39(3):285-6. doi: 10.1016/j.amepre.2010.05.002.
10
A minimum 6-month prolonged abstinence should be required for evaluating smoking cessation trials.评估戒烟试验应要求至少6个月的长期戒烟期。
Nicotine Tob Res. 2003 Apr;5(2):151-3. doi: 10.1080/0955300031000083427.
引用本文的文献
1
To assess the preparedness of primary care physicians in terms of their knowledge, attitude, beliefs, and confidence regarding smoking cessation in Gilgit.评估吉尔吉特地区基层医疗医生在戒烟知识、态度、信念和信心方面的准备情况。
J Family Med Prim Care. 2024 Oct;13(10):4605-4610. doi: 10.4103/jfmpc.jfmpc_435_24. Epub 2024 Oct 18.
2
A cost-utility analysis of the impact of electronic nicotine delivery systems on health care costs and outcomes in Canada.电子尼古丁传送系统对加拿大医疗成本和健康结果影响的成本-效用分析。
Health Promot Chronic Dis Prev Can. 2022 Jan;42(1):29-36. doi: 10.24095/hpcdp.42.1.05.
3
Multifactorial Etiology of Adolescent Nicotine Addiction: A Review of the Neurobiology of Nicotine Addiction and Its Implications for Smoking Cessation Pharmacotherapy.青少年尼古丁成瘾的多因素病因学：尼古丁成瘾的神经生物学及其对戒烟药物治疗的影响综述。
Front Public Health. 2021 Jul 5;9:664748. doi: 10.3389/fpubh.2021.664748. eCollection 2021.
4
Smoking cessation in individuals who use vaping as compared with traditional nicotine replacement therapies: a systematic review and meta-analysis.与传统尼古丁替代疗法相比，使用电子烟的个体戒烟情况：一项系统评价和荟萃分析。
BMJ Open. 2021 Feb 22;11(2):e044222. doi: 10.1136/bmjopen-2020-044222.
5
Acquaintance and Approach in the Direction of Tobacco Cessation Among Dental Practitioners-A Systematic Review.牙科从业者在戒烟方面的认知与方法——一项系统综述
Int J Prev Med. 2020 Oct 5;11:167. doi: 10.4103/ijpvm.IJPVM_316_19. eCollection 2020.
6
Sex Differences in Use of Smoking Cessation Services and Resources: A Real-World Study.戒烟服务与资源使用中的性别差异：一项现实世界研究
Tob Use Insights. 2020 Jan 22;13:1179173X20901500. doi: 10.1177/1179173X20901500. eCollection 2020.
7
Tobacco Use Cessation and Prevention - A Review.烟草使用的戒烟与预防——综述
J Clin Diagn Res. 2016 May;10(5):ZE13-7. doi: 10.7860/JCDR/2016/19321.7803. Epub 2016 May 1.
8
Breaking barriers in the genomics and pharmacogenetics of drug addiction.突破成瘾的基因组学和药物遗传学障碍。
Clin Pharmacol Ther. 2010 Dec;88(6):779-91. doi: 10.1038/clpt.2010.175. Epub 2010 Oct 27.
本文引用的文献
1
Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients.比较尼古丁替代疗法（NRT）加简短咨询、单纯简短咨询以及对住院患者戒烟进行最小干预的临床试验。
Thorax. 2003 Jun;58(6):484-8. doi: 10.1136/thorax.58.6.484.
2
Nicotine replacement therapy in smoking cessation.戒烟中的尼古丁替代疗法。
Thorax. 2003 Jun;58(6):464-5. doi: 10.1136/thorax.58.6.464.
3
Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting.单独使用尼古丁贴片与单独使用尼古丁鼻喷雾剂及联合使用二者治疗吸烟者的比较：在非专科环境下进行的一项最小干预随机多中心试验。
Nicotine Tob Res. 2003 Apr;5(2):181-7. doi: 10.1080/1462220031000073252.
4
Smoking cessation with nicotine replacement therapy among health care workers: randomized double-blind study.医护人员使用尼古丁替代疗法戒烟：随机双盲研究。
Croat Med J. 2003 Apr;44(2):219-24.
5
Nicotine replacement therapy for smoking cessation.用于戒烟的尼古丁替代疗法。
Cochrane Database Syst Rev. 2002(4):CD000146. doi: 10.1002/14651858.CD000146.
6
First-line pharmacotherapy for tobacco use and dependence.烟草使用与依赖的一线药物治疗。
J Am Board Fam Pract. 2002 Nov-Dec;15(6):489-97.
7
CYP2A6 genetic variation and potential consequences.细胞色素P450 2A6基因变异及其潜在影响。
Adv Drug Deliv Rev. 2002 Nov 18;54(10):1245-56. doi: 10.1016/s0169-409x(02)00065-0.
8
The prospects for immunotherapy in smoking cessation.免疫疗法在戒烟方面的前景。
Lancet. 2002 Oct 5;360(9339):1089-91. doi: 10.1016/S0140-6736(02)11134-2.
9
A randomized trial of sertraline as a cessation aid for smokers with a history of major depression.一项关于舍曲林作为有重度抑郁病史吸烟者戒烟辅助药物的随机试验。
Am J Psychiatry. 2002 Oct;159(10):1731-7. doi: 10.1176/appi.ajp.159.10.1731.
10
Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation.拉扎贝胺，一种选择性、可逆性单胺氧化酶B抑制剂，用于辅助戒烟。
Addiction. 2002 Oct;97(10):1347-54. doi: 10.1046/j.1360-0443.2002.00258.x.
Zotero 插件